Drugs / sustained release tablet
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02103647 | May → Jun 2013 | — | IlDong Pharmaceutical Co Ltd | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sustained release tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02103647 ↗ |